

![]() |
Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient |
|
Authors | ||
Published in | International Journal of Infectious Diseases. 2017, vol. 55, p. 24-26 | |
Abstract | Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal infection was treated with surgical treatment and posaconazole delayed-release tablets. This strategy allowed reaching high drug levels that could not be obtained with the posaconazole solution. | |
Keywords | Mucormycosis — Posaconazole delayed-release tablets — Rhizomucor pusillus — Zygomycosis | |
Identifiers | PMID: 27988409 | |
Full text | ||
Structures | ||
Research groups | Transplantation et hépatologie (905) Groupe Laurent Kaiser (virologie clinique) (668) | |
Citation (ISO format) | ANDREY, Diego Olivier et al. Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient. In: International Journal of Infectious Diseases, 2017, vol. 55, p. 24-26. https://archive-ouverte.unige.ch/unige:93784 |